Pharmacokinetics of Low Molecular Weight [dalteparin] and Unfractionated Heparin in Pregnancy

Trial Profile

Pharmacokinetics of Low Molecular Weight [dalteparin] and Unfractionated Heparin in Pregnancy

Completed
Phase of Trial: Phase II

Latest Information Update: 07 Nov 2016

At a glance

  • Drugs Dalteparin sodium (Primary) ; Heparin (Primary)
  • Indications Pregnancy; Spontaneous abortion; Thrombosis
  • Focus Pharmacokinetics
  • Most Recent Events

    • 20 May 2016 Status changed from active, no longer recruiting to completed.
    • 17 Feb 2009 Planned end date changed from 1 Mar 2010 to 1 Mar 2012 as reported by ClinicalTrials.gov.
    • 15 Aug 2008 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top